Sector dividends Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Stocks
ROVI
ES0157261019
Pharmaceuticals
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.92 EUR | -0.64% |
|
+0.26% | -7.90% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 0.62% | 0.69% | 32.14x | 19.18x | 11.69x | 24.07x | 24.55x | 980B | ||
| 2.34% | 2.44% | 24.41x | 6.15x | 5.63x | 15.32x | 16.94x | 550B | ||
| 3.17% | 3.34% | 26.86x | -788.07x | 6.49x | 13.28x | 13.63x | 382B | ||
| 3.14% | 3.21% | 17x | 6.31x | 4.23x | 10.41x | 11.74x | 317B | ||
| 1.92% | 2.02% | 21.82x | 5.08x | 4.57x | 12.95x | 13.62x | 270B | ||
| 3.05% | 3.13% | 20.35x | 6.1x | 5.28x | 12.82x | 14x | 269B | ||
| 4.05% | 3.89% | 12.43x | 5.41x | 4.64x | 9.55x | 11.14x | 191B | ||
| 2.99% | 3.16% | 21.95x | 16.37x | 5.91x | 10.33x | 13.54x | 182B | ||
| 2.62% | 2.68% | -44.34x | 8.41x | 5.36x | 29.54x | 59.61x | 154B | ||
| 6.95% | 6.92% | 11.79x | 1.64x | 3.11x | 7.57x | 8.81x | 144B | ||
| -.--% | -.--% | 25.82x | 5.18x | 7.81x | 17.62x | 18.34x | 115B | ||
| 4.66% | 4.79% | 10.58x | 4.68x | 2.93x | 7.84x | 8.52x | 110B | ||
| 3.74% | 3.96% | 12.35x | 4.45x | 2.72x | 7.99x | 9.01x | 102B | ||
| 5.8% | 6.15% | 10.91x | 1.17x | 2.1x | 6.78x | 7.71x | 101B | ||
| 1.81% | 2.07% | 24.38x | 5.54x | 8.31x | 15.72x | 16.44x | 77.35B | ||
| 3.97% | 4.06% | 44.82x | 1.12x | 2.63x | 9.69x | 27.48x | 49.43B | ||
| 0.56% | 0.63% | 34.42x | 4.65x | 7.63x | 25.45x | 26.3x | 47.38B | ||
| 0.6% | 1.99% | 15.78x | 1.29x | 1.5x | 7.1x | 11.81x | 41.89B | ||
| Average | 2.89% | 3.06% | 17.97x | -38.07x | 5.14x | 13.56x | 17.40x | 226.74B | |
| Weighted average by Cap. | 2.46% | 2.56% | 21.09x | -65.24x | 6.66x | 15.74x | 18.10x |
Select your edition
All financial news and data tailored to specific country editions
















